Latest publications

Primary resistance to integrase strand-transfer inhibitors in Europe.

  • HIV Clinical and Translational Research
October 01, 2015
2015 Oct. J Antimicrob Chemother.70(10):2885-8. Epub 2015 Jul 17.
By:
  • Casadella M
  • van Ham PM
  • Noguera-Julian M
  • van Kessel A
  • Pou C
  • Hofstra LM
  • Santos JR
  • Garcia F
  • Struck D
  • Alexiev I
  • Bakken Kran AM
  • Hoepelman AI
  • Kostrikis LG
  • Somogyi S
  • Liitsola K
  • Linka M
  • Nielsen C
  • Otelea D
  • Paraskevis D
  • Poljak M
  • Puchhammer-Stockl E
  • Stanekova D
  • Stanojevic M
  • Van Laethem K
  • Zidovec Lepej S
  • Clotet B
  • Boucher CA
  • Paredes R
  • Wensing AM
  • SPREAD programme (Schmit J.C. as investigator for this programme).

Increased extrafollicular expression of the B-cell stimulatory molecule CD70 in HIV-1-infected individuals.

  • HIV Clinical and Translational Research
September 10, 2015
2015 Sep. AIDS.29(14):1757-66.
By:
  • Lantto R
  • Nasi A
  • Sammicheli S
  • Amu S
  • Fievez V
  • Moutschen M
  • Pensieroso S
  • Hejdeman B
  • Chiodi F
  • Rethi B.

Global dispersal pattern of HIV type 1 subtype CRF01_AE: A genetic trace of human mobility related to heterosexual activities centralized in South-East Asia.

  • HIV Clinical and Translational Research
June 01, 2015
2015 Jun. J Infect Dis.211(11):1735-44. Epub 2014 Dec 15.
By:
  • Angelis K
  • Albert J
  • Mamais I
  • Magiorkinis G
  • Hatzakis A
  • Hamouda O
  • Struck D
  • Vercauteren J
  • Wensing AM
  • Alexiev I
  • Asjo B
  • Balotta C
  • Camacho RJ
  • Coughlan S
  • Griskevicius A
  • Grossman Z
  • Horban A
  • Kostrikis LG
  • Lepej S
  • Liitsola K
  • Linka M
  • Nielsen C
  • Otelea D
  • Paredes R
  • Poljak M
  • Puchhammer-Stockl E
  • Schmit JC
  • Sonnerborg A
  • Stanekova D
  • Stanojevic M
  • Boucher CA
  • Kaplan L
  • Vandamme AM
  • Paraskevis D.

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.

  • Immuno-Pharmacology and Interactomics
  • HIV Clinical and Translational Research
June 01, 2015
2015 Jun. J Antimicrob Chemother.70(6):1850-7. Epub 2015 Mar 3.
By:
  • Swartz JE
  • Vandekerckhove L
  • Ammerlaan H
  • de Vries AC
  • Begovac J
  • Bierman WF
  • Boucher CA
  • van der Ende ME
  • Grossman Z
  • Kaiser R
  • Levy I
  • Mudrikova T
  • Paredes R
  • Perez-Bercoff D
  • Pronk M
  • Richter C
  • Schmit JC
  • Vercauteren J
  • Zazzi M
  • Zidovec Lepej S
  • De Luca A
  • Wensing AM
  • European Society for translational Antiviral Research.

Near full-length characterization and population dynamics of the Human Immunodeficiency Virus type I Circulating Recombinant Form 42 (CRF42_BF) in Luxembourg.

  • HIV Clinical and Translational Research
  • Immuno-Pharmacology and Interactomics
May 01, 2015
2015 May. AIDS Res Hum Retroviruses.31(5):554-8. Epub 2015 Mar 6.
By:
  • Struck D
  • Roman F
  • De Landtsheer S
  • Servais JY
  • Lambert C
  • Masquelier C
  • Venard V
  • Ruelle J
  • Nijhuis M
  • Schmit JC
  • Seguin-Devaux C.

Transmission of HIV-1 Drug Resistance. In Handbook of Antimicrobial Resistance. (Book Chapter)

  • HIV Clinical and Translational Research
February 07, 2015
2015 Feb. Gotte M, Berghuis A, Matlashewski G, Wainberg M and Sheppard D, eds. New York: Springer, 2015. p.1-20. ISBN 978-1-4939-0693-2.
By:
  • Hofstra LM
  • Schmit J-C
  • Wensing AJ.

Anti-HIV activity of fucoidans from three brown seaweed species.

  • HIV Clinical and Translational Research
January 22, 2015
2015 Jan. Carbohydr Polym.115:122-8. Epub 2014 Sep 2.
By:
  • Thuy TT
  • Ly BM
  • Van TT
  • Quang NV
  • Tu HC
  • Zheng Y
  • Seguin-Devaux C
  • Mi B
  • Ai U.

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

  • HIV Clinical and Translational Research
January 01, 2015
2015 Jan. J Viral Hepat.22 Suppl 1:46-73.
By:
  • Gane E
  • Kershenobich D
  • Seguin-Devaux C
  • Kristian P
  • Aho I
  • Dalgard O
  • Shestakova I
  • Nymadawa P
  • Blach S
  • Acharya S
  • Anand AC
  • Andersson MI
  • Arendt V
  • Arkkila P
  • Baatarkhuu O
  • Barclay K
  • Ben-Ari Z
  • Bergin C
  • Bessone F
  • Blokhina N
  • Brunton CR
  • Choudhuri G
  • Chulanov V
  • Cisneros L
  • Croes EA
  • Dahgwahdorj YA
  • Daruich JR
  • Dashdorj NR
  • Davaadorj D
  • de Knegt RJ
  • de Vree M
  • Gadano AC
  • Gower E
  • Halota W
  • Hatzakis A
  • Henderson C
  • Hoffmann P
  • Hornell J
  • Houlihan D
  • Hrusovsky S
  • Jarcuska P
  • Kostrzewska K
  • Leshno M
  • Lurie Y
  • Mahomed A
  • Mamonova N
  • Mendez-Sanchez N
  • Mossong J
  • Norris S
  • Nurmukhametova E
  • Oltman M
  • Oyunbileg J
  • Oyunsuren T
  • Papatheodoridis G
  • Pimenov N
  • Prins M
  • Puri P
  • Radke S
  • Rakhmanova A
  • Razavi H
  • Razavi-Shearer K
  • Reesink HW
  • Ridruejo E
  • Safadi R
  • Sagalova O
  • Sanchez Avila JF
  • Sanduijav R
  • Saraswat V
  • Schreter I
  • Shah SR
  • Shevaldin A
  • Shibolet O
  • Silva MO
  • Sokolov S
  • Sonderup M
  • Souliotis K
  • Spearman CW
  • Staub T
  • Stedman C
  • Strebkova EA
  • Struck D
  • Sypsa V
  • Tomasiewicz K
  • Undram L
  • van der Meer AJ
  • van Santen D
  • Veldhuijzen I
  • Villamil FG
  • Willemse S
  • Zuckerman E
  • Zuure FR
  • Prabdial-Sing N
  • Flisiak R
  • Estes C.

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

  • HIV Clinical and Translational Research
January 01, 2015
2015 Jan. J Viral Hepat.22 Suppl 1:26-45.
By:
  • Hatzakis A
  • Chulanov V
  • Gadano AC
  • Bergin C
  • Ben-Ari Z
  • Mossong J
  • Schreter I
  • Baatarkhuu O
  • Acharya S
  • Aho I
  • Anand AC
  • Andersson MI
  • Arendt V
  • Arkkila P
  • Barclay K
  • Bessone F
  • Blach S
  • Blokhina N
  • Brunton CR
  • Choudhuri G
  • Cisneros L
  • Croes EA
  • Dahgwahdorj YA
  • Dalgard O
  • Daruich JR
  • Dashdorj NR
  • Davaadorj D
  • de Knegt RJ
  • de Vree M
  • Estes C
  • Flisiak R
  • Gane E
  • Gower E
  • Halota W
  • Henderson C
  • Hoffmann P
  • Hornell J
  • Houlihan D
  • Hrusovsky S
  • Jarcuska P
  • Kershenobich D
  • Kostrzewska K
  • Kristian P
  • Leshno M
  • Lurie Y
  • Mahomed A
  • Mamonova N
  • Mendez-Sanchez N
  • Norris S
  • Nurmukhametova E
  • Nymadawa P
  • Oltman M
  • Oyunbileg J
  • Oyunsuren T
  • Papatheodoridis G
  • Pimenov N
  • Prabdial-Sing N
  • Prins M
  • Radke S
  • Rakhmanova A
  • Razavi-Shearer K
  • Reesink HW
  • Ridruejo E
  • Safadi R
  • Sagalova O
  • Sanchez Avila JF
  • Sanduijav R
  • Saraswat V
  • Seguin-Devaux C
  • Shah SR
  • Shestakova I
  • Shevaldin A
  • Shibolet O
  • Silva MO
  • Sokolov S
  • Sonderup M
  • Souliotis K
  • Spearman CW
  • Staub T
  • Stedman C
  • Strebkova EA
  • Struck D
  • Sypsa V
  • Tomasiewicz K
  • Undram L
  • van der Meer AJ
  • van Santen D
  • Veldhuijzen I
  • Villamil FG
  • Willemse S
  • Zuckerman E
  • Zuure FR
  • Puri P
  • Razavi H.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

  • HIV Clinical and Translational Research
January 01, 2015
2015 Jan. J Viral Hepat.22 Suppl 1:6-25.
By:
  • Saraswat V
  • Norris S
  • de Knegt RJ
  • Sanchez Avila JF
  • Sonderup M
  • Zuckerman E
  • Arkkila P
  • Stedman C
  • Acharya S
  • Aho I
  • Anand AC
  • Andersson MI
  • Arendt V
  • Baatarkhuu O
  • Barclay K
  • Ben-Ari Z
  • Bergin C
  • Bessone F
  • Blach S
  • Blokhina N
  • Brunton CR
  • Choudhuri G
  • Chulanov V
  • Cisneros L
  • Croes EA
  • Dahgwahdorj YA
  • Dalgard O
  • Daruich JR
  • Dashdorj NR
  • Davaadorj D
  • de Vree M
  • Estes C
  • Flisiak R
  • Gadano AC
  • Gane E
  • Halota W
  • Hatzakis A
  • Henderson C
  • Hoffmann P
  • Hornell J
  • Houlihan D
  • Hrusovsky S
  • Jarcuska P
  • Kershenobich D
  • Kostrzewska K
  • Kristian P
  • Leshno M
  • Lurie Y
  • Mahomed A
  • Mamonova N
  • Mendez-Sanchez N
  • Mossong J
  • Nurmukhametova E
  • Nymadawa P
  • Oltman M
  • Oyunbileg J
  • Oyunsuren T
  • Papatheodoridis G
  • Pimenov N
  • Prabdial-Sing N
  • Prins M
  • Puri P
  • Radke S
  • Rakhmanova A
  • Razavi H
  • Razavi-Shearer K
  • Reesink HW
  • Ridruejo E
  • Safadi R
  • Sagalova O
  • Sanduijav R
  • Schreter I
  • Seguin-Devaux C
  • Shah SR
  • Shestakova I
  • Shevaldin A
  • Shibolet O
  • Sokolov S
  • Souliotis K
  • Spearman CW
  • Staub T
  • Strebkova EA
  • Struck D
  • Tomasiewicz K
  • Undram L
  • van der Meer AJ
  • van Santen D
  • Veldhuijzen I
  • Villamil FG
  • Willemse S
  • Zuure FR
  • Silva MO
  • Sypsa V
  • Gower E.

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso.

  • HIV Clinical and Translational Research
October 31, 2014
2014 Oct. PLoS One.9(10):e111240.
By:
  • Coulibaly M
  • Meda N
  • Yonaba C
  • Ouedraogo S
  • Congo M
  • Barry M
  • Thio E
  • Siribie I
  • Koueta F
  • Ye D
  • Kam L
  • Blanche S
  • Van De Perre P
  • Leroy V
  • MONOD Study Group ANRS 12206 (Seguin-Devaux C as collaborator for this project).

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.

  • HIV Clinical and Translational Research
October 01, 2014
2014 Oct. Nucleic Acids Res.42(18):e144. Epub 2014 Aug 12.
By:
  • Struck D
  • Lawyer G
  • Ternes AM
  • Schmit JC
  • Bercoff DP.

Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naive HIV-2-infected patient.

  • HIV Clinical and Translational Research
September 24, 2014
2014 Sep. AIDS.28(15):2329-31.
By:
  • Zheng Y
  • Lambert C
  • Arendt V
  • Seguin-Devaux C.

Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.

  • HIV Clinical and Translational Research
August 01, 2014
2014 Aug. J Biomol Struct Dyn.32(8):1274-89. Epub 2013 Jul 22.
By:
  • Arumugam K
  • Crouzy S
  • Chevigne A
  • Seguin-Devaux C
  • Schmit JC.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

  • HIV Clinical and Translational Research
July 21, 2014
2014 Jul. BMC Infect Dis.14:407.
By:
  • Frentz D
  • Van de Vijver DA
  • Abecasis AB
  • Albert J
  • Hamouda O
  • Jorgensen LB
  • Kucherer C
  • Struck D
  • Schmit JC
  • Vercauteren J
  • Asjo B
  • Balotta C
  • Beshkov D
  • Camacho RJ
  • Clotet B
  • Coughlan S
  • Griskevicius A
  • Grossman Z
  • Horban A
  • Kolupajeva T
  • Korn K
  • Kostrikis LG
  • Liitsola K
  • Linka M
  • Nielsen C
  • Otelea D
  • Paraskevis D
  • Paredes R
  • Poljak M
  • Puchhammer-Stockl E
  • Sonnerborg A
  • Stanekova D
  • Stanojevic M
  • Van Wijngaerden E
  • Wensing AM
  • Boucher CA
  • Spread Programme.

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

  • HIV Clinical and Translational Research
May 28, 2014
2014 May. J Am Heart Assoc.3(3):e000844.
By:
  • Nordell AD
  • McKenna M
  • Borges AH
  • Duprez D
  • Neuhaus J
  • Neaton JD
  • INSIGHT SMART Study Group (Schmit JC as collaborator)
  • ESPRIT Study Group
  • SILCAAT Scientific Committee.

Patterns of transmitted HIV drug resistance in Europe vary by risk group.

  • HIV Clinical and Translational Research
April 10, 2014
2014 Apr. PLoS One.9(4):e94495.
By:
  • Frentz D
  • van de Vijver D
  • Abecasis A
  • Albert J
  • Hamouda O
  • Jorgensen L
  • Kucherer C
  • Struck D
  • Schmit JC
  • Vercauteren J
  • Asjo B
  • Balotta C
  • Bergin C
  • Beshkov D
  • Camacho R
  • Clotet B
  • Griskevicius A
  • Grossman Z
  • Horban A
  • Kolupajeva T
  • Korn K
  • Kostrikis L
  • Linka KL
  • Nielsen C
  • Otelea D
  • Paraskevis D
  • Paredes R
  • Poljak M
  • Puchhammer-Stockl E
  • Sonnerborg A
  • Stanekova D
  • Stanojevic M
  • Vandamme AM
  • Boucher C
  • Wensing A
  • SPREAD Programme.

Factors associated with D-dimer levels in HIV-infected individuals.

  • HIV Clinical and Translational Research
March 13, 2014
2014 Mar. PLoS One.9(3):e90978.
By:
  • Borges AH
  • O'Connor JL
  • Phillips AN
  • Baker JV
  • Vjecha MJ
  • Losso MH
  • Klinker H
  • Lopardo G
  • Williams I
  • Lundgren JD
  • INSIGHT SMART Study Group (Schmit JC as collaborator)
  • ESPRIT Study Group
  • SILCAAT Scientific Committee.

What is the significance of posttreatment control of HIV infection vis-a-vis functional cure?

  • HIV Clinical and Translational Research
February 20, 2014
2014 Feb. AIDS.28(4):603-5.
By:
  • Vanham G
  • Buve A
  • Florence E
  • Seguin-Devaux C
  • Saez-Cirion A.

Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.

  • HIV Clinical and Translational Research
February 01, 2014
2014 Feb. J Clin Microbiol.52(2):517-23. Epub 2013 Dec 4.
By:
  • Swenson LC
  • Cobb B
  • Geretti AM
  • Harrigan PR
  • Poljak M
  • Seguin-Devaux C
  • Verhofstede C
  • Wirden M
  • Amendola A
  • Boni J
  • Bourlet T
  • Huder JB
  • Karasi JC
  • Zidovec Lepej S
  • Lunar MM
  • Mukabayire O
  • Schuurman R
  • Tomazic J
  • Van Laethem K
  • Vandekerckhove L
  • Wensing AM.